<sentence id="0">Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor .</sentence>
<sentence id="1">The product of the von Hippel-Lindau gene , pVHL , targets the alpha subunits of the heterodimeric transcription factor hypoxia-inducible factor ( HIF ) for polyubiquitination in the presence of oxygen .</sentence>
<sentence id="2">The binding of pVHL to HIF is governed by the enzymatic hydroxylation of conserved prolyl residues within peptidic motifs present in the HIFalpha family members .</sentence>
<sentence id="3">By using a biochemical purification strategy , we have identified a human homolog of Caenorhabditis elegans Egl9 as a HIF prolyl hydroxylase .</sentence>
<sentence id="4">In addition , we studied the activity of a structurally diverse collection of low molecular weight inhibitors of procollagen prolyl 4-hydroxylase as potential inhibitors of the HIF hydroxylase .</sentence>
<sentence id="5">A model compound of this series stabilized HIF in a variety of cells , leading to the increased production of its downstream target , vascular endothelial growth factor .</sentence>